Cargando…
S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA
Autores principales: | Ramberger, Evelyn, Dolnik, Anna, Ng, Yuen Lam Dora, Ziehm, Matthias, Popp, Oliver, Sträng, Eric, Kull, Miriam, Sapozhnikova, Valeriia, Grünschläger, Florian, Benary, Manuela, Müller, Sina, Gao, Xiang, Murgai, Arunima, Haji, Mohamed, Schmidt, Annika, Lutz, Raphael, Nogai, Axel, Braune, Jan, Laue, Dominik, Langer, Christian, Khandanpour, Cyrus, Bassermann, Florain, Döhner, Hartmut, Engelhardt, Monika, Straka, Christian, Hundemer, Michael, Haas, Simon, Beule, Dieter, Keller, Ulrich, Einsele, Hermann, Bullinger, Lars, Knop, Stefan, Mertins, Philipp, Krönke, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428325/ http://dx.doi.org/10.1097/01.HS9.0000967668.47651.05 |
Ejemplares similares
-
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
por: Heynen, Guus J. J. E., et al.
Publicado: (2022) -
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
por: Ng, Yuen Lam Dora, et al.
Publicado: (2022) -
Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation
por: Braune, Jan, et al.
Publicado: (2022) -
P855: SYNERGISTIC EFFICACY OF COMBINED SUMOYLATION AND PROTEASOME INHIBITION IN MULTIPLE MYELOMA
por: Keller, U., et al.
Publicado: (2022) -
Leveraging
Ligand Affinity and Properties: Discovery
of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs
por: Steinebach, Christian, et al.
Publicado: (2023)